Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Dec;18(6):861–866. doi: 10.1111/j.1365-2125.1984.tb02556.x

Flurbiprofen interaction with single doses of atenolol and propranolol.

J Webster, J C Petrie, I McLean, G M Hawksworth
PMCID: PMC1463692  PMID: 6529525

Abstract

In patients with mild hypertension, flurbiprofen in a dose of 100 mg daily for 7 days attenuated the hypotensive effect of a single dose of propranolol 80 mg but not of atenolol 100 mg. The attenuation was not due to an effect on the pharmacokinetic profile of either propranolol or atenolol. An alternative explanation is required.

Full text

PDF
861

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartter F. C., Gill J. R., Jr, Frolich J. C., Bowden R. E., Hollifield J. W., Radfar N., Keiser H. R., Oates J. A., Seyberth H., Taylor A. A. Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Trans Assoc Am Physicians. 1976;89:77–91. [PubMed] [Google Scholar]
  2. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs. 1979 Dec;18(6):417–438. doi: 10.2165/00003495-197918060-00001. [DOI] [PubMed] [Google Scholar]
  3. Bühler F. R., Laragh J. H., Baer L., Vaughan E. D., Jr, Brunner H. R. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med. 1972 Dec 14;287(24):1209–1214. doi: 10.1056/NEJM197212142872401. [DOI] [PubMed] [Google Scholar]
  4. Chalmers I. M., Bell M. A., Buchanan W. W. Effect of flurbiprofen on the metabolism of antipyrine in man. Ann Rheum Dis. 1973 Jan;32(1):58–61. doi: 10.1136/ard.32.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Di Salle E., Baker K. M., Bareggi S. R., Watkins W. D., Chidsey C. A., Frigerio A., Morselli P. L. A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr. 1973 Sep 26;84(2):347–353. doi: 10.1016/s0021-9673(01)91714-5. [DOI] [PubMed] [Google Scholar]
  6. Durão V., Prata M. M., Gonçalves L. M. Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet. 1977 Nov 12;2(8046):1005–1007. doi: 10.1016/s0140-6736(77)92899-9. [DOI] [PubMed] [Google Scholar]
  7. Geyskes G. G., Boer P., Vos J., Dorhout Mees E. J. Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol. Lancet. 1976 May 15;1(7968):1049–1051. doi: 10.1016/s0140-6736(76)92222-4. [DOI] [PubMed] [Google Scholar]
  8. Harms H. H., Gooren L., Spoelstra A. J., Hesse C., Verschoor L. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. Br J Clin Pharmacol. 1978 Jan;5(1):19–26. doi: 10.1111/j.1365-2125.1978.tb01593.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Petrie J. C., Galloway D. B., Webster J., Simpson W. T., Lewis J. A. Atenolol and bendrofluazide in hypertension. Br Med J. 1975 Oct 18;4(5989):133–135. doi: 10.1136/bmj.4.5989.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Raine A. E., Pickering T. G. Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade. Br Med J. 1977 Jul 9;2(6079):90–92. doi: 10.1136/bmj.2.6079.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rubin P., Jackson G., Blaschke T. Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin. Br J Clin Pharmacol. 1980 Jul;10(1):33–39. doi: 10.1111/j.1365-2125.1980.tb00499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Salvetti A., Arzilli F., Pedrinelli R., Beggi P., Motolese M. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Eur J Clin Pharmacol. 1982;22(3):197–201. doi: 10.1007/BF00545214. [DOI] [PubMed] [Google Scholar]
  13. Scales B., Copsey P. B. The gas chromatographic determination of atenolol in biological samples. J Pharm Pharmacol. 1975 Jun;27(6):430–433. doi: 10.1111/j.2042-7158.1975.tb09473.x. [DOI] [PubMed] [Google Scholar]
  14. Smith S. R., Gibson R., Bradley D., Kendall M. J. Failure of indomethacin to modify beta-adrenoceptor blockade. Br J Clin Pharmacol. 1983 Feb;15(2):267–268. doi: 10.1111/j.1365-2125.1983.tb01497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Watkins J., Abbott E. C., Hensby C. N., Webster J., Dollery C. T. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J. 1980 Sep 13;281(6242):702–705. doi: 10.1136/bmj.281.6242.702. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES